Clinical trial
The Application of SERS and Metabolomics in Sepsis
NCT02213237 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Application of SERS and Metabolomics in Sepsis
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 31, 2011
- Completion date
- December 31, 2018
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.